Skip to main content
TipRanks
Go Ultimate75% OFF

ARS Pharmaceuticals (SPRY) Q2 2026 Earnings Report

593 Followers

SPRY Q2 2026 EPS Results

Actual EPS
-$0.63
Consensus EPS
-$0.48
Beat/Miss
Missed by -$0.15
One Year Ago EPS
-$0.46

SPRY Q2 2026 Revenue Results

Actual Revenue
$33.66M
Expected Revenue
$31.32M
Beat/Miss
Beat by +$2.34M
YoY Revenue Growth
+114.15%

Earnings Announcement Details

Quarter
Q2 2026
Date
08/13/2026
Time
After Close
Conference Call
Thursday, August 13, 2026
SPRY Upcoming Earnings

ARS Pharmaceuticals's next earnings date is estimated for March 25, 2027, based on past reporting schedules.

Q2 2026 Earnings Call Audio

SPRY Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

SPRY Earnings History

SPRY earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 25, 20272026 (Q4)-0.28--0.41――
Nov 05, 20262026 (Q3)-0.30-0.36-0.5230.77% (+0.16)
Aug 13, 20262026 (Q2)-0.48-0.63-0.46-36.96% (-0.17)
May 15, 20262026 (Q1)-0.52-0.61-0.35-74.29% (-0.26)
Mar 09, 20262025 (Q4)-0.43-0.410.48-185.42% (-0.89)
Nov 10, 20252025 (Q3)-0.45-0.52-0.2-160.00% (-0.32)
Aug 13, 20252025 (Q2)-0.46-0.46-0.13-253.85% (-0.33)
May 14, 20252025 (Q1)-0.34-0.35-0.11-218.18% (-0.24)
Mar 20, 20252024 (Q4)-0.240.48-0.07785.71% (+0.55)
Nov 13, 20242024 (Q3)-0.14-0.20-0.16-25.00% (-0.04)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed